Tsutomu Arakawa, Ph.D.
President and Director of Protein Chemistry
Before co-founding A.P.L. in 1998 Tsutomu spent over 14 years in Protein Chemistry at Amgen as Research Scientist and Lab Head. His group there was responsible for protein purification and characterization for discovery research and pre-formulation studies. While there he purified dozens of recombinant proteins and characterized their structure, function, and stability. He also pioneered the application of on-line light scattering methods and the use of FTIR to study dried proteins and how excipients affect their structure and activity.
Prior to working at Amgen, Tsutomu was a postdoctoral fellow with Carl Frieden at Washington University studying tubulin self-assembly and its interactions with actin. During his earlier postdoctoral studies with Serge Timasheff at Brandeis he studied mechanisms of solvent effects on protein stability and solubility and helped to develop the preferential interaction theory to explain the stabilizing effects of excipients such as sugars. He received his Ph.D. in Biochemistry in 1977 from Osaka Prefectural University.
Tsutomu has authored 300 scientific publications, listed here, including over 250 directly related to his work in biotechnology and pharmaceuticals.
Vice President, CFO, and Director of Biophysical Chemistry
Before co-founding A.P.L. in 1998 John spent over 6 years in Protein Chemistry at Amgen, where his primary responsibilities were protein characterization using analytical ultracentrifugation, light scattering, and calorimetry. While there he pioneered new sedimentation velocity techniques appropriate for biotechnology products and new software techniques for analysis of protein-receptor interactions by sedimentation equilibrium.
Prior to working at Amgen, John was a faculty member in Molecular and Cell Biology at the University of Connecticut in Storrs for 9 years studying protein structure and function. While at U. Conn. he founded and headed the Macromolecular Characterization Facility in the Biotechnology Center and was a co-founder of the National Analytical Ultracentrifugation Facility. John was also a postdoctoral fellow at U. Conn. with Todd Schuster studying hemoglobin kinetics. He received his Ph.D. in Physics from Stanford in 1977.
John has authored 90 scientific publications, listed here, including over 70 directly related to biotechnology and pharmaceutical applications.
Before joining APL in 2013 Karl was an Assistant Professor in the Department of Pharmaceutical Sciences at University of Colorado Denver for 6 years, where he studied virus assembly and DNA-protein interactions via AUC, fluorescence, stopped-flow kinetics, and other biophysical, biochemical, and thermodynamic approaches.
Prior to that Karl did postdoctoral work at U.C. Denver with Dr. Carlos Catalano and at the University of Iowa with Dr. Michael Feiss. Karl obtained his Ph.D. in Molecular Biophysics at Washington University School of Medicine under Dr. Timothy Lohman in 2003.
Karl has authored 24 scientific publications, listed here, including 10 involving AUC.
All text, images, and downloadable documents are © copyright 2000-2013, Alliance Protein Laboratories Inc.